Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Cardiovascular Diseases × Liraglutide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 3 Obesity 2 Infertility 1 Cardiovascular Diseases 1

Interventions

sofosbuvir-velpatasvir drug combination 1 amlodipine, atorvastatin drug combination 1 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1 Vitamin B 6 1 Vitamin B 12 1 Tumor Necrosis Factor Inhibitors 1 Rosuvastatin Calcium 1 Progesterone 1 Omeprazole 1 Naproxen 1 Liraglutide 1 Gonadotropin-Releasing Hormone 1 Geritol 1 Folic Acid 1 Febuxostat 1 Estradiol 1 Colchicine 1 Cholecalciferol 1 Chocolate 1 Atorvastatin 1 Antirheumatic Agents 1 Allopurinol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02073929 2019-02-28

LIPT

Herlev Hospital

Phase 4 Completed

72 enrolled 18 charts

Cardiovascular Diseases, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡